We aimed to assess the diagnostic performance of the boston criteria version 2.0 for caa diagnosis in a cohort of individuals ranging from cognitively normal to dementia in the community and memory clinic settings. We report an international collaborative study aiming to update and externally validate the boston diagnostic criteria across the full spectrum of clinical caa presentations. We investigated whether the new v2.0 criteria change ich recurrence risk in patients with probable caa
Search OnlyFans - SecretFans, Discover the Best Website to Connect with
We assessed ich recurrence risk in consecutive patients with ich and available brain magnetic resonance imaging
Patients with macrovascular or structural causes were excluded.
The boston criteria are used worldwide for in vivo diagnosis of cerebral amyloid angiopathy (caa) but have not been updated since 2010, prior to emergence of additional mri markers.